News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
200 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (356)
2 (311)
3 (275)
4 (220)
5 (5)
6 (13)
7 (269)
8 (259)
9 (234)
10 (254)
11 (151)
12 (8)
13 (5)
14 (231)
15 (262)
16 (229)
17 (233)
18 (106)
19 (13)
20 (5)
21 (200)
22 (226)
23 (228)
24 (236)
25 (117)
26 (12)
27 (4)
28 (256)
29 (245)
30 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Pharm Country
Webcast of VILTEPSO® (viltolarsen) injection: Long-Term Data Scheduled for Presentation at the PPMD 2021 Virtual Annual Conference
NS Pharma, Inc. announces a webcast during the PPMD 2021 Virtual Annual Conference held from June 23 to 26 .
June 21, 2021
·
2 min read
Biotech Beach
Dr. Jeffrey S. Miller to Present on Progress of GTB-3550 TriKE™ Phase I Trial Accompanying GT Biopharma’s Company Presentation at Raymond James Human Health Innovation Conference
GT Biopharma, Inc.today announced that Dr. Jeffrey S. Miller will be giving an update on the progress of the GTB-3550 TriKE™ Phase I trial accompanying the Company’s corporate update presentation at the upcoming Raymond James Human Health Innovation Conference on Tuesday, June 22, 2021 at 11:20 AM ET.
June 21, 2021
·
1 min read
Business
Epredia And Aiforia Announce Partnership For Global Distribution Of AI-powered Pathology Software
Epredia, and Aiforia, have announced today that they have entered into a commercial distribution agreement for Aiforia’s comprehensive portfolio of workflow enhancing solutions which enable pathologists to harness the power of deep learning AI for image analysis.
June 21, 2021
·
3 min read
Pharm Country
Peer-Reviewed Study Suggests Nerivio® Effective for Treatment of Acute Menstrual Migraine Headache
Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, announced today that a new peer-reviewed study published in Pain and Therapy demonstrates the efficacy of Nerivio® in treating menstrual migraine.
June 21, 2021
·
3 min read
Genetown
Boston IVF Partners with TMRW Life Sciences to Adopt State-of-the-Art Technology for the Safe Management of Eggs and Embryos
Boston IVF, a leading fertility clinic with more than 25 locations across the U.S., announced that it has partnered with TMRW Life Sciences, Inc. to bring unprecedented technology and automation to its cryostorage and fertility cell management practices.
June 21, 2021
·
4 min read
Pharm Country
Virpax to Use Envelta™ IND Enabling Study Results for Two Additional Indications
Virpax ® Pharmaceuticals, Inc. today announced that the Investigational New Drug (IND) Application enabling studies for Envelta™ will also be used as a source for INDs for two additional indications for cancer pain.
June 21, 2021
·
4 min read
Agitation in Delirium Management Market - North America has been a highly promising regional market| TMR Research Study
Agitation and delirium are common occurrences in patients in intensive care units. The associated symptoms are marked by acute cerebral insufficiency arising out of structural and/or physiological abnormalities.
June 21, 2021
·
3 min read
Drug Development
Albireo Announces Expanded Phase 3 Data on Bylvay™ (odevixibat) and A3907 at Upcoming EASL International Liver Congress
Albireo Pharma, Inc., a clinical-stage rare liver disease company developing novel bile acid modulators, announced new data in nine accepted abstracts to be presented at EASL International Liver Congress™ 2021 on June 23 – 26.
June 21, 2021
·
15 min read
Drug Development
NovaBiotics Announces Cysteamine Bitartrate (NM002) Included in REMAP-CAP Phase 3 Clinical Trial for Community Acquired Pneumonia
NovaBiotics Ltd, a privately held clinical stage company developing novel immune based therapies for life-threatening and life-limiting-diseases, announces that the Company’s proprietary intravenous cysteamine bitartrate therapy candidate is included in a global Phase 3 clinical trial being conducted and funded as part of REMAP-CAP.
June 21, 2021
·
4 min read
Drug Development
Tarsus Pharmaceuticals, Inc. Announces Positive Results of Saturn-1 Pivotal Trial Evaluating TP-03 for the Treatment of Demodex Blepharitis
Tarsus Pharmaceuticals, Inc. announced that all pre-specified primary and secondary endpoints were met for its pivotal Phase 2b/3 Saturn-1 trial evaluating the company’s novel investigational therapeutic, TP-03, in patients with Demodex blepharitis.
June 21, 2021
·
14 min read
Previous
7 of 20
Next